Integrating Community Hospitals into Cell & Gene Therapy Supply Chains

•  Discussing key challenges and mitigation strategies
• Enabling decentralized and mobile collection models to support community hospitals without on-site collection or processing facilities
• Implementing just-in-time delivery and alternative storage strategies to address limited ln2 infrastructure and ensure day-of-infusion readiness
• Aligning sponsors, manufacturers, logistics providers, and community hospitals with emerging FACT and BSR/PDA standards to support compliant transport, storage, and administration

Speakers:

Lizette Caballero

Associate Director - Clinical & Cell Therapy Liaison

Johnson & Johnson